Bionano announced a significant study published in the American Journal of Hematology demonstrating the utility of optical genome mapping (OGM) in detecting structural variants associated with ...

SAN DIEGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication demonstrating the use of optical genome mapping (OGM) to identify structural variations ...

SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 2 of Bionano Symposium 2026, which focused on New Frontiers in Oncology and ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

Bionano Genomics announced that Al Luderer, Ph.D., chairman of the company’s Board of Directors, has been appointed interim president and chief executive officer effective May 5, 2026. Luderer will ...

Good day, and welcome to the Bionano First Quarter 2024 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to David Holmes from ...

Follow Bionano Genomics as investors assess optical genome mapping, the current catalyst, execution risks and the company evidence that may shape its next market move.

Bionano Genomics, Inc. announced a settlement agreement that modifies its existing senior secured convertible debentures due in May 2024. The amendment defers the December 2024 amortization payment ...

SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication from a team led by Manon Delafoy from the Institut Necker Enfants Malades ...

Welcome to the H.C. Wainwright 27th Annual Global Investment Conference. I'm Dr. Katherine Degen, an associate biotech research analyst at the firm. I'd like to take a moment to welcome Erik Holmlin ...

BioNano Genomics has announced a major virtual event aimed at engaging the scientific community directly. The newly revealed "Bionano Symposium 2026" is designed to showcase the capabilities of its ...

The average one-year price target for Bionano Genomics (BMV:BNGO) has been revised to MX$89.76 / share. This is a decrease of 11.11% from the prior estimate of MX$100.98 dated October 1, 2026. These ...